Ultragenyx Pharmaceutical
Ultragenyxâ„¢ develops therapeutics for rare diseases, sometimes referred to as Orphan products. Founded in 2010, the company is led by Emil Kakkis, M.D., Ph.D., former CMO of BioMarin Pharmaceutical. Efficient and effective development strategies...Homepage: http://www.ultragenyx.com/
Total money raised: $45M
94949
77 Digital Drive
Suite 210
Novato
USA CA
Suite 210
Novato
USA CA
Phone: 415.884.0223 x107
Updated on Jan 11, 2013
Ultragenyx Pharmaceutical at CrunchBase
Emil D. Kakkis President & CEOUltragenyx Pharmaceutical at CrunchBase
Shalini Sharp SVP Finance & CFO
Thomas Kassberg Chief Business Officer and Senior Vice President
Past
June, 2011
Ultragenyx Pharmaceutical raised $45M in a Series A round from TPG Biotechnology Partners, Fidelity Biosciences, HealthCap, and Pappas Ventures
Ultragenyx Pharmaceutical Closes $45M Series A Financing 
finsmes.com